Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ETON Eton Pharmaceuticals, Inc.

Trading 10-09 09:59:14 EDT

56.01

+1.26

+2.30%

High56.01	Low54.76	Vol21.90K
Open54.86	D1 Closing54.75	Amplitude2.29%
Mkt Cap1.60B	Tradable Cap1.25B	Total Shares28.58M
T/O1.21M	T/O Rate0.10%	Tradable Shares22.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ETON","market":"US","secType":"STK","nameCN":"Eton Pharmaceuticals, Inc.","latestPrice":56.01,"timestamp":1791554346973,"preClose":54.75,"halted":0,"volume":21902,"delay":0,"changeRate":0.02301369863013695,"floatShares":22304300,"shares":28583135,"eps":0.39,"marketStatus":"Trading","change":1.26,"latestTime":"10-09 09:59:14 EDT","open":54.86,"high":56.01,"low":54.7568,"amount":1207847.706954,"amplitude":0.022889,"askPrice":55.64,"askSize":39,"bidPrice":54.67,"bidSize":300,"shortable":3,"etf":0,"ttmEps":0.39,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1541739600000,"exchange":"NASDAQ","adjPreClose":54.75,"preHourTrading":{"tag":"盘前","latestPrice":54.1,"preClose":54.75,"latestTime":"08:02 EDT","volume":1683,"amount":92470.225221,"timestamp":1791547348108,"change":-0.65,"changeRate":-0.011872,"amplitude":0.068475},"postHourTrading":{"tag":"盘后","latestPrice":54.75,"preClose":54.75,"latestTime":"19:30 EDT","volume":134239,"amount":7349574.75,"timestamp":1791502204490,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.479994,"impliedVol":0.6337,"impliedVolPercentile":0.3227},"requestUrl":"/m/hq/s/ETON","defaultTab":"news","newsList":[{"id":"2673109779","title":"Is Impavido Launch Altering The Investment Case For Eton Pharmaceuticals (ETON)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673109779","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673109779?lang=en_us&edition=fundamental","pubTime":"2026-10-07 18:26","pubTimestamp":1791368768,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals recently launched IMPAVIDO (miltefosine) capsules in the US for multiple forms of leishmaniasis in eligible patients 12 years and older who weigh at least 30 kg.\nThe IMPAVIDO release adds a commercially available antileishmanial therapy to Eton Pharmaceuticals' rare disease franchise and expands its portfolio into a highly specialized infectious disease segment with complex safety and monitoring needs.\nThe focus now turns to how Eton Pharmaceuticals' rare disease...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/is-impavido-launch-altering-the-investment-case-for-eton-pha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/is-impavido-launch-altering-the-investment-case-for-eton-pha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065988","title":"Eton Pharma Chief Business Officer David Krempa Sells 4,166 Common Shares for $229,405.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065988","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065988?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:50","pubTimestamp":1791319802,"startTime":"0","endTime":"0","summary":"Eton Pharma Chief Business Officer David Krempa sells 4,166 common shares for $229,405.56Eton Pharmaceuticals Chief Business Officer David Krempa sold 4,166 common shares on Oct. 6, 2026 at USD 55.066","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL5QFG6d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharma Chief Business Officer David Krempa Sells 4,166 Common Shares for $229,405.56","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672678126","title":"Eton Pharmaceuticals Down over 15%, on Pace for Largest Percent Decrease Since November 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2672678126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672678126?lang=en_us&edition=fundamental","pubTime":"2026-10-01 02:39","pubTimestamp":1790793540,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc.  is currently at $50.20, down $8.99 or 15.19%--Would be lowest close since Aug. 13, 2026, when it closed at $40.80--On pace for largest percent decrease since Nov. 10, 2023, when it fell 15.23%--Snaps a two day winning streak--Down 16.94% month-to-date--Up 196.87% year-to-date--Down 22.09% from its all-time closing high of $64.43 on Aug. 24, 2026--Up 147.78% from 52 weeks ago , when it closed at $20.26--Down 22.09% from its 52-week closing high of $64.43 on Aug. 24, 2026--Up 249.83% from its 52-week closing low of $14.35 on Feb. 5, 2026--Traded as low as $50.12; lowest intraday level since Aug. 13, 2026, when it hit $40.66--Down 15.32% at today's intraday low; largest intraday percent decrease since March 18, 2025, when it fell as much as 16.74%All data as of 2:37:59 PM ETSource: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234379","title":"Eton Pharmaceuticals Launches Impavido Capsules to Treat Leishmaniasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234379","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234379?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:37","pubTimestamp":1790595423,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals  said Monday that it launched Impavido  capsules to treat leishmaniasis, a parasitic disease, in adults and adolescents aged 12 and older weighing at least 30 kilograms.The company said its Eton Cares program will provide patient support services, including $0 co-pay for eligible commercially insured patients, while it works to expand hospital availability through a consignment inventory program.Eton also said it will offer an emergency access pathway for urgent patient needs through Anovo Specialty Pharmacy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239912","title":"Eton Pharmaceuticals - Holds Exclusive Commercialization Rights for Impavido in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239912?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA82RRT6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670123991","title":"Eton Pharmaceuticals Announces U.S. Commercial Availability of Impavido® (Miltefosine) Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2670123991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670123991?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA82RRT6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663631015","title":"Eton Pharma Director Paul V. Maier Reports Disposal of Common Shares Worth $2.94 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663631015","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663631015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:52","pubTimestamp":1787950326,"startTime":"0","endTime":"0","summary":"Eton Pharma director Paul V. Maier reports disposal of common shares worth $2.94 millionEton Pharmaceuticals director Paul V. Maier exercised employee stock options for 50,000 shares at USD 3.78 on Au","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL4fdqL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharma Director Paul V. Maier Reports Disposal of Common Shares Worth $2.94 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662070625","title":"Eton Pharmaceuticals Hosts One-on-One Investor Meetings at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662070625","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662070625?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:50","pubTimestamp":1787827817,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals hosts one-on-one investor meetings at Wells Fargo Healthcare ConferenceEton Pharmaceuticals will hold 1x1 investor meetings on Sept. 9, 2026 at the Wells Fargo Healthcare Conferen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDLbnLgpc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BQXX3F31.USD","SG9999014039.USD","SG9999014021.USD","ETON","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014005.SGD","BK4588","LU2210150020.SGD","IE00BQXX3C00.GBP","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","BK4585","NDAQ","IE00B64PRP62.GBP","BK4007","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662572059","title":"Eton Pharmaceuticals (ETON) Stock May Be Fully Valued Following Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2662572059","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662572059?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:32","pubTimestamp":1787797949,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals stock has delivered very strong multiyear returns, yet the broader valuation checks currently lean expensive and raise questions about how much optimism is already in the price.\n\nEton Pharmaceuticals has returned over 12x in the past 3 years, which places recent gains at an unusually high level compared with many small pharma peers.\nRecent business momentum around its rare disease and pediatric portfolio can support high expectations, while any setback in product...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/eton-pharmaceuticals-eton-stock-may-be-fully-valued-followin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/eton-pharmaceuticals-eton-stock-may-be-fully-valued-followin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TSPA","ETON","BK4007","CDIG","TACU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662525209","title":"Eton Pharma Chief Business Officer David Krempa Reports Disposal of 25,000 Common Shares Valued at $1.63 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662525209","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662525209?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:20","pubTimestamp":1787606422,"startTime":"0","endTime":"0","summary":"Eton Pharma Chief Business Officer David Krempa reports disposal of 25,000 common shares valued at $1.63 millionEton Pharmaceuticals Chief Business Officer David Krempa sold 25,000 common shares on Au","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL2TmKsb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharma Chief Business Officer David Krempa Reports Disposal of 25,000 Common Shares Valued at $1.63 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661249820","title":"Eton Pharmaceuticals (ETON) Returns To Profit As Valuation Debate Gets Harder To Ignore","url":"https://stock-news.laohu8.com/highlight/detail?id=2661249820","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661249820?lang=en_us&edition=fundamental","pubTime":"2026-08-24 05:15","pubTimestamp":1787519702,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals (ETON) drew investor attention on 13 August 2026 after reporting stronger second quarter earnings and a return to profitability, along with higher full year 2026 revenue guidance of at least US$145 million.\nSee our latest analysis for Eton Pharmaceuticals.\nEton Pharmaceuticals’ latest earnings announcement comes after a strong run in the stock, with a 30 day share price return of 49.03% and a 1 year total shareholder return of 266.88%. This adds to very large 3 and 5 year...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/eton-pharmaceuticals-eton-returns-to-profit-as-valuation-deb","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/eton-pharmaceuticals-eton-returns-to-profit-as-valuation-deb","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","DCF","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302922","title":"Eton Pharma President and CEO Sean Brynjelsen Sells USD 6.19 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302922","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302922?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:26","pubTimestamp":1787264817,"startTime":"0","endTime":"0","summary":"Eton Pharma President and CEO Sean Brynjelsen sells USD 6.19 million in common sharesEton Pharmaceuticals President and CEO Sean Brynjelsen sold 100,000 common shares on Aug. 19-20, SEC filing shows.S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL5jNDCn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharma President and CEO Sean Brynjelsen Sells USD 6.19 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660107109","title":"Dow Falls Over 100 Points, Records Weekly Loss: Investor Sentiment Weakens, but Fear Index Remains in ‘Greed’ Zone","url":"https://stock-news.laohu8.com/highlight/detail?id=2660107109","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660107109?lang=en_us&edition=fundamental","pubTime":"2026-08-17 14:41","pubTimestamp":1786948873,"startTime":"0","endTime":"0","summary":"The Fear &amp; Greed Index, which measures market sentiment, declined while remaining in the Greed zone. U.S. stocks closed lower, with the Dow Jones falling over 100 points.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/08/61238820/dow-falls-over-100-points-records-weekly-loss-investor-sentiment-weakens-but-fear-index-remains-in-greed-zone","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4145","XP","LU0072463663.USD","LU2360107168.USD","IE00B19Z4B17.USD","LU0196696701.USD","LU1861220207.SGD","LU1861220033.SGD","BK4095","BK4127","LU1051769294.HKD","LU0651946864.USD","ETON","IE00B66KJ199.SGD","LU1861217088.USD","KLC","LU0196696453.USD","LU0572108347.SGD","LU0788109048.HKD","LU0047713382.USD","BK4007","IE0031619046.USD","LU0050427557.USD","LU1861215975.USD","LU2125910500.SGD","IE00B7SZL793.SGD","LU0651947912.USD","LU0531971322.HKD","LU2290526834.HKD","FN","LU1051768304.USD","PCOM","FLXS","LU1515016050.SGD","BK4122","BK4585","BK4204","LU2045819591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659817200","title":"Eton Pharmaceuticals price target raised to $70 from $40 at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2659817200","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659817200?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:21","pubTimestamp":1786886479,"startTime":"0","endTime":"0","summary":"B. Riley analyst Madison El-Saadi raised the firm’s price target on Eton Pharmaceuticals (ETON) to $70 from $40 and keeps a Buy rating on the share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eton-pharmaceuticals-price-target-raised-to-70-from-40-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eton-pharmaceuticals-price-target-raised-to-70-from-40-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129647","title":"Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129647","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129647?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:20","pubTimestamp":1786738826,"startTime":"0","endTime":"0","summary":"Emmaus Life Sciences Q2 revenue soars on licensing dealOverviewUS biopharmaceutical firm's Q2 revenue rose 124% yr/yr, driven by NIT license agreementCompany reduced operating expenses following sales","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","EMMA","RANI","BK4539","MGTX","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659812665","title":"Eton Pharmaceuticals is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2659812665","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659812665?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:31","pubTimestamp":1786735860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ETON/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659237101","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2659237101","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659237101?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:26","pubTimestamp":1786728378,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals  reported Q2 adjusted earnings and revenue above market expectations and raised full-year 2026 sales guidance late Thursday.Shares soared 39% amid a surge in intraday trading volume to over 1.29 million from a daily average of about 472,000.Star Equity  entered into a merger agreement to acquire Harte Hanks . The deal values Harte at $5 per share, or about $38.4 million in terms of equity value.Shares of Harte Hanks surged 51% as intraday trading volume catapulted to over 3.98 million from a daily average of roughly 6,000.International Money Express  shares were up more than 23% after Western Union's  pending acquisition of the company received approval from the New York State Department of Financial Services, with Western Union agreeing to certain commitments related to remittance services and locations.Over 3.89 million shares of International Money Express traded intraday, versus a daily average of roughly 436,000.Price: 56.95, Change: +16.15, Percent Change: +3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WU","BK4585","BK4196","BK4088","BK4106","STRR","BK4227","BK4007","ETON","IMXI","BK4130","BK4009","HHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659499201","title":"Scienture Q2 Revenue Surges on Rezenopy Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2659499201","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659499201?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:17","pubTimestamp":1786709821,"startTime":"0","endTime":"0","summary":"Scienture Q2 revenue surges on REZENOPY launchOverviewUS specialty pharma firm's Q2 revenue rose sharply, driven by commercial launch of REZENOPYQ2 gross margin reached 97.7%, reflecting growing comme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","OMER","BK4167","BK4139","BK4007","ETON","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659146461","title":"B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2659146461","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659146461?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:55","pubTimestamp":1786708528,"startTime":"0","endTime":"0","summary":"B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659463611","title":"U.S. Stocks on the MOVE-Reddit, Capricor Therapeutics, Birkenstock","url":"https://stock-news.laohu8.com/highlight/detail?id=2659463611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659463611?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:40","pubTimestamp":1786707611,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Reddit, Capricor Therapeutics, BirkenstockAugust 14 (Reuters)-U.S. stock index futures were subdued on Friday, a day after the S&P 500 closed at a record high, as rising c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL6N44B0Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQG","LU0127658192.USD","LU0942090050.USD","SMAX","LU1868837300.USD","LU2517655374.HKD","LU0348723411.USD","LU1267930813.SGD","BK4585","TSPY","IJH","LU0553294199.USD","VTV","IE00BQXX3D17.EUR","BK4588","TDV","SPMO","LU0274383776.USD","SG9999002224.SGD","LU0354030511.USD","LU1868836914.USD","BK4613","LU0061475181.USD","BK4518","LU0444971666.USD","BK4077","RDTL","SH","LU2458330169.SGD","LU2089284900.SGD","ACWI","CHPS","LU0079474960.USD","YSPY","LU1989763005.USD","RCAT","LU1046421795.USD","WDAY","LU0738911758.USD","ETON","LU2111349929.HKD","SPLV","LU1989773731.SGD","LU1815333072.USD","WUGI","BMAY","LU2106854487.HKD","SPYQ","BK4146","LU0061474705.USD","LU2023250504.SGD","GPIX",".SPX","ALLW","SPYV","LU0889565833.HKD","IE00BQXX3F31.USD","RSPA","HIBS","VV","LU1917777945.USD","SG9999002232.USD","BK4526","BK4551","LU1003077747.HKD","LU0061474960.USD","LU1868837136.USD","RDVI","LU0683600562.USD","SPYM","BK4216","LU1974910355.USD","RLX","LU0096364046.USD","RDDT","ITOT","SPXS","VEU","LU0719512351.SGD","XLG","BK4581","LU0476273544.USD","PSI","LU0787776722.HKD","LU2413666426.HKD","LU2247934214.USD","LU1868836591.USD","SPY","IJR","LU0957808578.USD","LU2265009873.SGD","RDYY","SHOC","BIRK","LU0949170772.SGD","EPAI","LU2290526834.HKD","LU0661504455.SGD","VOOG","UPRO","IE0004445239.USD","LU0109392836.USD","BK4563","BK4519","SOCL","BK4157","LU0082616367.USD","BK4547","GB00BDT5M118.USD","IE00BSNM7G36.USD","NOBL","VOO","LU1069344957.HKD","LU1935042991.SGD","LU2413666699.HKD","JEPI","RSPN","LU0198837287.USD","TINY","BK4528","IE0009356076.USD","MMAX","LU1868836757.USD","SPDN","IE00BD6J9T35.USD","BK4139","BK4534","DRNZ","VTI","LU1721428933.USD","LU0545039389.USD","LU2896262040.SGD","SPYD","SPUS","XYLD","BK4125","BK4548","DMAX","LU0314104364.USD","MOAT","SPYU","LU2211814178.USD","BK4567","LU0354030438.USD","RDVY","SPUU","LU0444973449.USD","04336","ETFT","LU0158827781.USD","LU1935043536.SGD","RCAX","LU1674673428.USD","LU2931357623.SGD","LU0276348264.USD","LU1153585028.USD","LU0889566641.SGD","SMH","ZNTL","LU0011850046.USD","DBSC","IE00BQXX3C00.GBP","IVE","LU0868494617.USD","LU2517655028.SGD","LU1861215975.USD","BK4023","SPXU","BK4147","LU0096362180.USD","SG9999001424.SGD","BK4187","IVV","UMAC","LU1235294995.USD","LU1778281490.HKD","LU0238689110.USD","BK4603","LU1823568750.SGD","SPGP","SPHQ","LU2028103732.USD","IVW","SPYG","LU0957791311.USD","LU1642822529.SGD","BK4533","LU2271345857.HKD","LU2517655291.USD","LU0210536198.USD","LU1674673691.USD","BK4516","BK4075","HIBL","IE00BFXG1179.USD","BK4007","AMAT","LU1691799644.USD","LU1815336760.USD","LU2023251221.USD","SDS","FOXA","SPYH","LU1861220033.SGD","LU0347712357.USD","LU0868494708.USD","IE00B5949003.HKD","AVXX","LU0158827948.USD","VBK","SOXQ","SSO","LU1035775433.USD","LU0097036916.USD","LU0175139822.USD","LU1804176565.USD","LU2023250843.SGD","RSP","BK4543","SCHX","XNTK","SPHD","GSLC","LU2360107168.USD","RSPU","AVAV","SCHB","XDTE","CAPR","PUSA","LU1803068979.SGD","SFY","SPXL","LU0289960550.SGD","LU0081259029.USD","LU2089985449.USD","LU2458330243.SGD","LU2089283258.USD","LU0792757196.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.etonpharma.com","stockEarnings":[{"period":"1week","weight":0.0533},{"period":"1month","weight":-0.0774},{"period":"3month","weight":0.4955},{"period":"6month","weight":1.077},{"period":"1year","weight":1.6159},{"period":"ytd","weight":2.2377}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0104},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.139},{"period":"1year","weight":0.1498},{"period":"ytd","weight":0.1349}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.049574},{"month":2,"riseRate":0.5,"avgChangeRate":0.007501},{"month":3,"riseRate":0.5,"avgChangeRate":0.000763},{"month":4,"riseRate":0.375,"avgChangeRate":0.041311},{"month":5,"riseRate":0.625,"avgChangeRate":0.018979},{"month":6,"riseRate":0.25,"avgChangeRate":-0.044284},{"month":7,"riseRate":0.5,"avgChangeRate":0.004018},{"month":8,"riseRate":0.75,"avgChangeRate":0.169767},{"month":9,"riseRate":0.5,"avgChangeRate":0.04526},{"month":10,"riseRate":0.625,"avgChangeRate":0.067145},{"month":11,"riseRate":0.571429,"avgChangeRate":0.051311},{"month":12,"riseRate":0.625,"avgChangeRate":0.051914}],"exchange":"NASDAQ","name":"Eton Pharmaceuticals, Inc.","nameEN":"Eton Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Eton Pharmaceuticals, Inc.,ETON,Eton Pharmaceuticals, Inc.股票,Eton Pharmaceuticals, Inc.股票老虎,Eton Pharmaceuticals, Inc.股票老虎国际,Eton Pharmaceuticals, Inc.行情,Eton Pharmaceuticals, Inc.股票行情,Eton Pharmaceuticals, Inc.股价,Eton Pharmaceuticals, Inc.股市,Eton Pharmaceuticals, Inc.股票价格,Eton Pharmaceuticals, Inc.股票交易,Eton Pharmaceuticals, Inc.股票购买,Eton Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction